[Detection of tissue antibodies and long-term prognosis in liver diseases--a catamnestic matched-pair study].

Of 1270 consecutive patients with liver diseases of various types we have examined the blood serum on autoimmune antibodies against cell nuclei (ANA), smooth muscle (SMA) and vascular endothelium. 98 patients (7.7%) had antibodies of one of the above.

[Alternative tumor therapy].

Our knowledge about the biology of malignant growth has changed. The tumor cell is not absolutely autonomous. The reactions of the host organism are important (e.

[Therapy of acute attacks of gout using acemetacin (author's transl)].

In an open clinical study the efficacy and tolerability of [1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetoxy] acetic acid (acemetacin, TV 1322, Rantudil) were studied in 15 patients (2 female and 13 male) suffering from acute arthritis urica. Basing on the heterogeneity of the patients it was possible to estimate the minimal dose of acemetacin necessary to treat slight, moderately severe and extremely severe forms of the complaint. With the exception of one patient who suffered from an extremely severe attack of gout, all patients were completely free from pain within 7 days of therapy.

Criteria for the evaluation of cytostatic chemotherapy.

The evaluation of cytostatic chemotherapy is difficult because the criteria are multivarious and the system for testing is complex. The clinical trial only is a reliable method. But the clnical trial require a cooperative study and a cooperative study is very expansive.

[Immunotherapy of cancer: reality or hope? (AUTHOR'S TRANSL)].

The reality of immunotherapy of cancer is still in the trial stages. Supportive immunotherapy combined with conventional cancer therapy can prolong the duration of remission and perhaps raise the cure rate for many neoplastic diseases such as acute leukemias, sarcomas and malignant melanomas. Our knowledge of the immunologic reactions is still incomplete.